Clinical trial
Candesartan's Effects on Alzheimer's Disease And Related Biomarkers
NCT02646982
Study timeline
Study start (unknown)2016-06-30Date precision: day
Registry last updated2022-12-01
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Mild Cognitive Impairmentunresolved
Interventions
PlaceboDRUG
CandesartanDRUG · verified · RxNorm: candesartan
Sponsors & collaborators
Emory Universitylead sponsor
National Institute on Aging (NIA)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02646982 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.